Diffusion Pharmaceuticals Inc

NASDAQ:DFFN

3.86

-0.14 (-3.50%)

6:53:31 PM EDT: $4.00 +0.14 (+3.63%)

Diffusion Pharmaceuticals Inc Stock, NASDAQ:DFFN

300 East Main Street, Suite 201, Charlottesville, Virginia 22902-8759

United States of America

Phone: +1.434.220.0718

Number of Employees: 13

http://www.diffusionpharma.com

Description

Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.